Purpose This study was designed to compare the efficacy and tolerability of the generic
formulation (Atorva®) and the reference formulation (Lipitor®) of atorvastatin, both at a …

BACKGROUND: A manufacturer of atorvastatin is seeking marketing approval in Korea of a
generic product for adult patients with primary hypercholesterolemia. OBJECTIVE: The …

Background The objective of this pilot study was to evaluate the comparative efficacy of
alternate-day dosing of atorvastatin compared with the standard once-daily dose based on …

The objective of this multicenter, randomized, open-label, parallel-group, 8-week study was
to evaluate the comparative dose efficacy of the 3-hydroxy-3-methylglutaryl coenzyme A …

Background: High-intensity atorvastatin dosing may lead to a greater incidence of adverse
events, subsequently leading to discontinuation and suboptimal risk reduction for major …

Data pooled from 21 atorvastatin clinical trials have been analyzed to establish the safety of
reducing low density lipoprotein cholesterol (LDL-C) levels below currently recommended …

Background: Since the 1990s a multitude of statin trials have definitively demonstrated the
ability of statin therapy to reduce the risk of adverse coronary heart disease (CHD) events …

This 1-year, double-blind, active-controlled, multicenter study compared the efficacy and
safety of atorvastatin to pravastatin and evaluated their ability to achieve target low-density …

The efficacy and safety of atorvastatin 10 mg versus simvastatin 20 mg and atorvastatin 80
mg versus simvastatin 80 mg was determined in a 6-week, prospective, randomized, open …